ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biodegradable Drug Eluting Stents Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-2M17046
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Biodegradable Drug Eluting Stents Market Research Report 2024
BUY CHAPTERS

Global Biodegradable Drug Eluting Stents Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-2M17046
Report
November 2025
Pages:143
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boston Scientific
Biotronik AG
Biosensors International
Terumo
MicroPort Scientific
Lepu Medical
JW Medical
SINOMED
Bio-Heart

Biodegradable Drug Eluting Stents Market

The global Biodegradable Drug Eluting Stents market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Biodegradable Polymer Drug-eluting Stents (BP-DES) are medical devices used in the treatment of coronary artery disease. Unlike traditional stents that use permanent polymer coatings to release drugs, BP-DES incorporate biodegradable polymers that gradually degrade over time, leaving behind only the bare metal stent. These stents are designed to release drugs, typically anti-proliferative or anti-inflammatory agents, to prevent restenosis (re-narrowing of the artery) after angioplasty. The biodegradable polymer technology reduces the risk of long-term complications associated with permanent polymer stents, such as inflammation and late stent thrombosis, while still providing effective drug delivery to inhibit cell growth and maintain vessel patency.
From a downstream perspective, Direct Selling accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Biodegradable Drug Eluting Stents leading manufacturers including Boston Scientific, Biotronik, Biosensors International, TERUMO, MicroPort Scientific, Lepu Medical, JW Medical, SINOMED, Bio-heart, etc., dominate supply; the top five capture approximately % of global revenue, with Boston Scientific leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Biodegradable Drug Eluting Stents market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Biodegradable Drug Eluting Stents Market Report

Report Metric Details
Report Name Biodegradable Drug Eluting Stents Market
Segment by Type
  • 30 Days
  • 60 Days
  • 90 Days
Segment by Application
  • Direct Selling
  • Distribution
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boston Scientific, Biotronik, Biosensors International, TERUMO, MicroPort Scientific, Lepu Medical, JW Medical, SINOMED, Bio-heart
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Biodegradable Drug Eluting Stents study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Biodegradable Drug Eluting Stents Market report?

Ans: The main players in the Biodegradable Drug Eluting Stents Market are Boston Scientific, Biotronik, Biosensors International, TERUMO, MicroPort Scientific, Lepu Medical, JW Medical, SINOMED, Bio-heart

What are the Application segmentation covered in the Biodegradable Drug Eluting Stents Market report?

Ans: The Applications covered in the Biodegradable Drug Eluting Stents Market report are Direct Selling, Distribution

What are the Type segmentation covered in the Biodegradable Drug Eluting Stents Market report?

Ans: The Types covered in the Biodegradable Drug Eluting Stents Market report are 30 Days, 60 Days, 90 Days

1 Study Coverage
1.1 Introduction to Biodegradable Drug Eluting Stents: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Biodegradable Drug Eluting Stents Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 30 Days
1.2.3 60 Days
1.2.4 90 Days
1.3 Market Segmentation by Application
1.3.1 Global Biodegradable Drug Eluting Stents Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Direct Selling
1.3.3 Distribution
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biodegradable Drug Eluting Stents Revenue Estimates and Forecasts 2020-2031
2.2 Global Biodegradable Drug Eluting Stents Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Biodegradable Drug Eluting Stents Sales Estimates and Forecasts 2020-2031
2.4 Global Biodegradable Drug Eluting Stents Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Biodegradable Drug Eluting Stents Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Biodegradable Drug Eluting Stents Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 30 Days Market Size by Manufacturers
3.5.2 60 Days Market Size by Manufacturers
3.5.3 90 Days Market Size by Manufacturers
3.6 Global Biodegradable Drug Eluting Stents Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Biodegradable Drug Eluting Stents Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Biodegradable Drug Eluting Stents Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Biodegradable Drug Eluting Stents Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Biodegradable Drug Eluting Stents Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Biodegradable Drug Eluting Stents Sales and Revenue by Type (2020-2031)
6.4 North America Biodegradable Drug Eluting Stents Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Biodegradable Drug Eluting Stents Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Biodegradable Drug Eluting Stents Sales and Revenue by Type (2020-2031)
7.4 Europe Biodegradable Drug Eluting Stents Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Biodegradable Drug Eluting Stents Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Biodegradable Drug Eluting Stents Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Biodegradable Drug Eluting Stents Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Biodegradable Drug Eluting Stents Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Biodegradable Drug Eluting Stents Sales and Revenue by Type (2020-2031)
9.4 Central and South America Biodegradable Drug Eluting Stents Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Biodegradable Drug Eluting Stents Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Biodegradable Drug Eluting Stents Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Biodegradable Drug Eluting Stents Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Biodegradable Drug Eluting Stents Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Boston Scientific
11.1.1 Boston Scientific Corporation Information
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Biodegradable Drug Eluting Stents Product Models, Descriptions and Specifications
11.1.4 Boston Scientific Biodegradable Drug Eluting Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Boston Scientific Biodegradable Drug Eluting Stents Sales by Product in 2024
11.1.6 Boston Scientific Biodegradable Drug Eluting Stents Sales by Application in 2024
11.1.7 Boston Scientific Biodegradable Drug Eluting Stents Sales by Geographic Area in 2024
11.1.8 Boston Scientific Biodegradable Drug Eluting Stents SWOT Analysis
11.1.9 Boston Scientific Recent Developments
11.2 Biotronik
11.2.1 Biotronik Corporation Information
11.2.2 Biotronik Business Overview
11.2.3 Biotronik Biodegradable Drug Eluting Stents Product Models, Descriptions and Specifications
11.2.4 Biotronik Biodegradable Drug Eluting Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Biotronik Biodegradable Drug Eluting Stents Sales by Product in 2024
11.2.6 Biotronik Biodegradable Drug Eluting Stents Sales by Application in 2024
11.2.7 Biotronik Biodegradable Drug Eluting Stents Sales by Geographic Area in 2024
11.2.8 Biotronik Biodegradable Drug Eluting Stents SWOT Analysis
11.2.9 Biotronik Recent Developments
11.3 Biosensors International
11.3.1 Biosensors International Corporation Information
11.3.2 Biosensors International Business Overview
11.3.3 Biosensors International Biodegradable Drug Eluting Stents Product Models, Descriptions and Specifications
11.3.4 Biosensors International Biodegradable Drug Eluting Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Biosensors International Biodegradable Drug Eluting Stents Sales by Product in 2024
11.3.6 Biosensors International Biodegradable Drug Eluting Stents Sales by Application in 2024
11.3.7 Biosensors International Biodegradable Drug Eluting Stents Sales by Geographic Area in 2024
11.3.8 Biosensors International Biodegradable Drug Eluting Stents SWOT Analysis
11.3.9 Biosensors International Recent Developments
11.4 TERUMO
11.4.1 TERUMO Corporation Information
11.4.2 TERUMO Business Overview
11.4.3 TERUMO Biodegradable Drug Eluting Stents Product Models, Descriptions and Specifications
11.4.4 TERUMO Biodegradable Drug Eluting Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 TERUMO Biodegradable Drug Eluting Stents Sales by Product in 2024
11.4.6 TERUMO Biodegradable Drug Eluting Stents Sales by Application in 2024
11.4.7 TERUMO Biodegradable Drug Eluting Stents Sales by Geographic Area in 2024
11.4.8 TERUMO Biodegradable Drug Eluting Stents SWOT Analysis
11.4.9 TERUMO Recent Developments
11.5 MicroPort Scientific
11.5.1 MicroPort Scientific Corporation Information
11.5.2 MicroPort Scientific Business Overview
11.5.3 MicroPort Scientific Biodegradable Drug Eluting Stents Product Models, Descriptions and Specifications
11.5.4 MicroPort Scientific Biodegradable Drug Eluting Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 MicroPort Scientific Biodegradable Drug Eluting Stents Sales by Product in 2024
11.5.6 MicroPort Scientific Biodegradable Drug Eluting Stents Sales by Application in 2024
11.5.7 MicroPort Scientific Biodegradable Drug Eluting Stents Sales by Geographic Area in 2024
11.5.8 MicroPort Scientific Biodegradable Drug Eluting Stents SWOT Analysis
11.5.9 MicroPort Scientific Recent Developments
11.6 Lepu Medical
11.6.1 Lepu Medical Corporation Information
11.6.2 Lepu Medical Business Overview
11.6.3 Lepu Medical Biodegradable Drug Eluting Stents Product Models, Descriptions and Specifications
11.6.4 Lepu Medical Biodegradable Drug Eluting Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Lepu Medical Recent Developments
11.7 JW Medical
11.7.1 JW Medical Corporation Information
11.7.2 JW Medical Business Overview
11.7.3 JW Medical Biodegradable Drug Eluting Stents Product Models, Descriptions and Specifications
11.7.4 JW Medical Biodegradable Drug Eluting Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 JW Medical Recent Developments
11.8 SINOMED
11.8.1 SINOMED Corporation Information
11.8.2 SINOMED Business Overview
11.8.3 SINOMED Biodegradable Drug Eluting Stents Product Models, Descriptions and Specifications
11.8.4 SINOMED Biodegradable Drug Eluting Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 SINOMED Recent Developments
11.9 Bio-heart
11.9.1 Bio-heart Corporation Information
11.9.2 Bio-heart Business Overview
11.9.3 Bio-heart Biodegradable Drug Eluting Stents Product Models, Descriptions and Specifications
11.9.4 Bio-heart Biodegradable Drug Eluting Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Bio-heart Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Biodegradable Drug Eluting Stents Industry Chain
12.2 Biodegradable Drug Eluting Stents Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Biodegradable Drug Eluting Stents Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Biodegradable Drug Eluting Stents Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Biodegradable Drug Eluting Stents Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Biodegradable Drug Eluting Stents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Boston Scientific
Biotronik AG
Biosensors International
Terumo
MicroPort Scientific
Lepu Medical
JW Medical
SINOMED
Bio-Heart
List of Tables
 Table 1. Global Biodegradable Drug Eluting Stents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Biodegradable Drug Eluting Stents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Biodegradable Drug Eluting Stents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Biodegradable Drug Eluting Stents Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Biodegradable Drug Eluting Stents Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Biodegradable Drug Eluting Stents Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Biodegradable Drug Eluting Stents Sales by Region (2020-2025) & (Units)
 Table 8. Global Biodegradable Drug Eluting Stents Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Biodegradable Drug Eluting Stents Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Biodegradable Drug Eluting Stents Sales Share by Manufacturers (2020-2025)
 Table 12. Global Biodegradable Drug Eluting Stents Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Biodegradable Drug Eluting Stents Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Biodegradable Drug Eluting Stents by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodegradable Drug Eluting Stents as of 2024)
 Table 16. Global Biodegradable Drug Eluting Stents Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Biodegradable Drug Eluting Stents Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Biodegradable Drug Eluting Stents Manufacturing Base and Headquarters
 Table 19. Global Biodegradable Drug Eluting Stents Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Biodegradable Drug Eluting Stents Sales by Type (2020-2025) & (Units)
 Table 23. Global Biodegradable Drug Eluting Stents Sales by Type (2026-2031) & (Units)
 Table 24. Global Biodegradable Drug Eluting Stents Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Biodegradable Drug Eluting Stents Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Biodegradable Drug Eluting Stents ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Biodegradable Drug Eluting Stents Sales by Application (2020-2025) & (Units)
 Table 29. Global Biodegradable Drug Eluting Stents Sales by Application (2026-2031) & (Units)
 Table 30. Biodegradable Drug Eluting Stents High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Biodegradable Drug Eluting Stents Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Biodegradable Drug Eluting Stents Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Biodegradable Drug Eluting Stents ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Biodegradable Drug Eluting Stents Growth Accelerators and Market Barriers
 Table 37. North America Biodegradable Drug Eluting Stents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Biodegradable Drug Eluting Stents Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Biodegradable Drug Eluting Stents Growth Accelerators and Market Barriers
 Table 40. Europe Biodegradable Drug Eluting Stents Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Biodegradable Drug Eluting Stents Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Biodegradable Drug Eluting Stents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Biodegradable Drug Eluting Stents Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Biodegradable Drug Eluting Stents Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Biodegradable Drug Eluting Stents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Biodegradable Drug Eluting Stents Investment Opportunities and Key Challenges
 Table 47. Central and South America Biodegradable Drug Eluting Stents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Biodegradable Drug Eluting Stents Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Biodegradable Drug Eluting Stents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Boston Scientific Corporation Information
 Table 51. Boston Scientific Description and Major Businesses
 Table 52. Boston Scientific Product Models, Descriptions and Specifications
 Table 53. Boston Scientific Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Boston Scientific Sales Value Proportion by Product in 2024
 Table 55. Boston Scientific Sales Value Proportion by Application in 2024
 Table 56. Boston Scientific Sales Value Proportion by Geographic Area in 2024
 Table 57. Boston Scientific Biodegradable Drug Eluting Stents SWOT Analysis
 Table 58. Boston Scientific Recent Developments
 Table 59. Biotronik Corporation Information
 Table 60. Biotronik Description and Major Businesses
 Table 61. Biotronik Product Models, Descriptions and Specifications
 Table 62. Biotronik Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Biotronik Sales Value Proportion by Product in 2024
 Table 64. Biotronik Sales Value Proportion by Application in 2024
 Table 65. Biotronik Sales Value Proportion by Geographic Area in 2024
 Table 66. Biotronik Biodegradable Drug Eluting Stents SWOT Analysis
 Table 67. Biotronik Recent Developments
 Table 68. Biosensors International Corporation Information
 Table 69. Biosensors International Description and Major Businesses
 Table 70. Biosensors International Product Models, Descriptions and Specifications
 Table 71. Biosensors International Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Biosensors International Sales Value Proportion by Product in 2024
 Table 73. Biosensors International Sales Value Proportion by Application in 2024
 Table 74. Biosensors International Sales Value Proportion by Geographic Area in 2024
 Table 75. Biosensors International Biodegradable Drug Eluting Stents SWOT Analysis
 Table 76. Biosensors International Recent Developments
 Table 77. TERUMO Corporation Information
 Table 78. TERUMO Description and Major Businesses
 Table 79. TERUMO Product Models, Descriptions and Specifications
 Table 80. TERUMO Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. TERUMO Sales Value Proportion by Product in 2024
 Table 82. TERUMO Sales Value Proportion by Application in 2024
 Table 83. TERUMO Sales Value Proportion by Geographic Area in 2024
 Table 84. TERUMO Biodegradable Drug Eluting Stents SWOT Analysis
 Table 85. TERUMO Recent Developments
 Table 86. MicroPort Scientific Corporation Information
 Table 87. MicroPort Scientific Description and Major Businesses
 Table 88. MicroPort Scientific Product Models, Descriptions and Specifications
 Table 89. MicroPort Scientific Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. MicroPort Scientific Sales Value Proportion by Product in 2024
 Table 91. MicroPort Scientific Sales Value Proportion by Application in 2024
 Table 92. MicroPort Scientific Sales Value Proportion by Geographic Area in 2024
 Table 93. MicroPort Scientific Biodegradable Drug Eluting Stents SWOT Analysis
 Table 94. MicroPort Scientific Recent Developments
 Table 95. Lepu Medical Corporation Information
 Table 96. Lepu Medical Description and Major Businesses
 Table 97. Lepu Medical Product Models, Descriptions and Specifications
 Table 98. Lepu Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Lepu Medical Recent Developments
 Table 100. JW Medical Corporation Information
 Table 101. JW Medical Description and Major Businesses
 Table 102. JW Medical Product Models, Descriptions and Specifications
 Table 103. JW Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. JW Medical Recent Developments
 Table 105. SINOMED Corporation Information
 Table 106. SINOMED Description and Major Businesses
 Table 107. SINOMED Product Models, Descriptions and Specifications
 Table 108. SINOMED Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. SINOMED Recent Developments
 Table 110. Bio-heart Corporation Information
 Table 111. Bio-heart Description and Major Businesses
 Table 112. Bio-heart Product Models, Descriptions and Specifications
 Table 113. Bio-heart Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Bio-heart Recent Developments
 Table 115. Key Raw Materials Distribution
 Table 116. Raw Materials Key Suppliers
 Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 118. Milestones in Production Technology Evolution
 Table 119. Distributors List
 Table 120. Market Trends and Market Evolution
 Table 121. Market Drivers and Opportunities
 Table 122. Market Challenges, Risks, and Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources


List of Figures
 Figure 1. Biodegradable Drug Eluting Stents Product Picture
 Figure 2. Global Biodegradable Drug Eluting Stents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 30 Days Product Picture
 Figure 4. 60 Days Product Picture
 Figure 5. 90 Days Product Picture
 Figure 6. Global Biodegradable Drug Eluting Stents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Direct Selling
 Figure 8. Distribution
 Figure 9. Biodegradable Drug Eluting Stents Report Years Considered
 Figure 10. Global Biodegradable Drug Eluting Stents Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Biodegradable Drug Eluting Stents Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Biodegradable Drug Eluting Stents Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Biodegradable Drug Eluting Stents Revenue Market Share by Region (2020-2031)
 Figure 14. Global Biodegradable Drug Eluting Stents Sales (2020-2031) & (Units)
 Figure 15. Global Biodegradable Drug Eluting Stents Sales (CAGR) by Region (2020-2031) (Units)
 Figure 16. Global Biodegradable Drug Eluting Stents Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Biodegradable Drug Eluting Stents Sales Volume Market Share in 2024
 Figure 18. Global Biodegradable Drug Eluting Stents Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. 30 Days Revenue Market Share by Manufacturer in 2024
 Figure 21. 60 Days Revenue Market Share by Manufacturer in 2024
 Figure 22. 90 Days Revenue Market Share by Manufacturer in 2024
 Figure 23. Global Biodegradable Drug Eluting Stents Sales Market Share by Type (2020-2031)
 Figure 24. Global Biodegradable Drug Eluting Stents Revenue Market Share by Type (2020-2031)
 Figure 25. Global Biodegradable Drug Eluting Stents Sales Market Share by Application (2020-2031)
 Figure 26. Global Biodegradable Drug Eluting Stents Revenue Market Share by Application (2020-2031)
 Figure 27. North America Biodegradable Drug Eluting Stents Sales YoY (2020-2031) & (Units)
 Figure 28. North America Biodegradable Drug Eluting Stents Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) in 2024
 Figure 30. North America Biodegradable Drug Eluting Stents Sales Volume (Units) by Type (2020- 2031)
 Figure 31. North America Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 32. North America Biodegradable Drug Eluting Stents Sales Volume (Units) by Application (2020-2031)
 Figure 33. North America Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 34. US Biodegradable Drug Eluting Stents Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada Biodegradable Drug Eluting Stents Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico Biodegradable Drug Eluting Stents Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe Biodegradable Drug Eluting Stents Sales YoY (2020-2031) & (Units)
 Figure 38. Europe Biodegradable Drug Eluting Stents Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) in 2024
 Figure 40. Europe Biodegradable Drug Eluting Stents Sales Volume (Units) by Type (2020-2031)
 Figure 41. Europe Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Europe Biodegradable Drug Eluting Stents Sales Volume (Units) by Application (2020-2031)
 Figure 43. Europe Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany Biodegradable Drug Eluting Stents Revenue (2020-2031) & (US$ Million)
 Figure 45. France Biodegradable Drug Eluting Stents Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Biodegradable Drug Eluting Stents Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Biodegradable Drug Eluting Stents Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Biodegradable Drug Eluting Stents Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Biodegradable Drug Eluting Stents Sales YoY (2020-2031) & (Units)
 Figure 50. Asia-Pacific Biodegradable Drug Eluting Stents Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific Biodegradable Drug Eluting Stents Sales Volume (Units) by Type (2020- 2031)
 Figure 53. Asia-Pacific Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 54. Asia-Pacific Biodegradable Drug Eluting Stents Sales Volume (Units) by Application (2020-2031)
 Figure 55. Asia-Pacific Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Indonesia Biodegradable Drug Eluting Stents Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan Biodegradable Drug Eluting Stents Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea Biodegradable Drug Eluting Stents Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan Biodegradable Drug Eluting Stents Revenue (2020-2031) & (US$ Million)
 Figure 60. India Biodegradable Drug Eluting Stents Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America Biodegradable Drug Eluting Stents Sales YoY (2020-2031) & (Units)
 Figure 62. Central and South America Biodegradable Drug Eluting Stents Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America Biodegradable Drug Eluting Stents Sales Volume (Units) by Type (2021-2031)
 Figure 65. Central and South America Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Central and South America Biodegradable Drug Eluting Stents Sales Volume (Units) by Application (2020-2031)
 Figure 67. Central and South America Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Brazil Biodegradable Drug Eluting Stents Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina Biodegradable Drug Eluting Stents Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa Biodegradable Drug Eluting Stents Sales YoY (2020-2031) & (Units)
 Figure 71. Middle East and Africa Biodegradable Drug Eluting Stents Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa Biodegradable Drug Eluting Stents Sales Volume (Units) by Type (2021-2031)
 Figure 74. South America Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Middle East and Africa Biodegradable Drug Eluting Stents Sales Volume (Units) by Application (2020-2031)
 Figure 76. Middle East and Africa Biodegradable Drug Eluting Stents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. GCC Countries Biodegradable Drug Eluting Stents Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey Biodegradable Drug Eluting Stents Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt Biodegradable Drug Eluting Stents Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa Biodegradable Drug Eluting Stents Revenue (2020-2025) & (US$ Million)
 Figure 81. Biodegradable Drug Eluting Stents Industry Chain Mapping
 Figure 82. Regional Biodegradable Drug Eluting Stents Manufacturing Base Distribution (%)
 Figure 83. Global Biodegradable Drug Eluting Stents Production Market Share by Region (2020-2031)
 Figure 84. Biodegradable Drug Eluting Stents Production Process
 Figure 85. Regional Biodegradable Drug Eluting Stents Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Biodegradable Polymer Drug eluting Stents BP DES Market Research Report 2024
Global Biodegradable Coated Drug eluting Stent Market Research Report 2024
Global Drug Eluting Coronary Stent Market Research Report 2025
Global Implantable Drug Eluting Stent Market Research Report 2024
Global Implantable Coronary Drug Eluting Stent Market Research Report 2024
Global Drug Eluting Coronary Stent System Market Research Report 2024
Global Bioabsorbable Eluting Coronary Stent System Market Research Report 2024
Global Bioresorbable Drug Eluting Stents Market Research Report 2025
Global Polymer Coronary Stents Market Research Report 2024
Global Biodegradable Coronary Stents Market Research Report 2024
Cardiovascular Drug Eluting Stents DES Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Eluting Stent System Market
Biodegradable and Bioabsorbable Stents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Eluting Peripheral Stents Market Research Report 2025
Global Polymeric Bioabsorbable Stents Market Research Report 2024
Global Peripheral Drug Eluting Stent Market Research Report 2025
Global Degradable Polymer Stent Market Research Report 2024
Global Biodegradable Gastrointestinal Stents Market Research Report 2025
Global Polymer Coated Stent Market Research Report 2024
Global Biodegradable Materials for Vascular Stents Market Research Report 2024

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Point-of-care Troponin Testing Instrument Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22I19939
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Troponin Analyzer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38W19812
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Anticoagulant Medications Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39V16824
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions